Dr Swathi Kaliki

Dr Swathi Kaliki

Dr Swathi Kaliki


Designation: Head, Department of Ophthalmic Plastic & Facial Aesthetic Surgery, Orbit & Ocular Oncology
Head, OEU Institute for Eye Cancer
Consultant Ophthalmologist
Adjunct Associate Professor, University of Rochester, USA.
Specialisation: Ophthalmic Plastic Surgery & Facial Aesthetics, Ocular Oncology Email: swathikaliki@lvpei.org Location: Kallam Anji Reddy Campus, Hyderabad

Swathi Kaliki is an internationally recognized Ocular Oncologist. She currently heads the Operation Eyesight Universal Institute for Eye Cancer and the Ophthalmic Plastic Services at the L V Prasad Eye Institute, India. She completed her primary medical education from Rajiv Gandhi University of Medical Sciences, Bangalore and M.S. Ophthalmology from NTR University of Health Sciences, Hyderabad. She completed her fellowship in Oculoplasty at the L V Prasad Eye Institute in 2010. She then trained in Ocular Oncology by world leaders of the field, Dr Jerry Shields and Dr Carol Shields, Wills Eye Institute, Philadelphia, USA, in 2011. The following year, she trained in Ocular pathology under world-renowned ocular pathologist Dr Ralph Eagle Jr of Wills Eye Institute, Philadelphia, USA. She then joined as a faculty at L V Prasad Eye Institute in 2013.

Dr Kaliki is the recipient of many prestigious awards including the AAO achievement, ICMR-Shakuntala Amir Chand Prize, APAO achievement, and IAPB Vision Excellence. In 2018, she served as a mentor for retinoblastoma activities in Nairobi under the grant received from Queen Elizabeth Diamond Jubilee Trust. She is also the brain behind 'Whitathon', an annual running event creating awareness about retinoblastoma and raising funds to support the treatment of children from financially distressed families with this deadly eye cancer. Held in association with Hyderabad Runners, Whitathon recently had its 3rd edition and 1st ever virtual edition in May 2021.

Dr Kaliki has extensively contributed to research in the field of ocular oncology. Description of the new condition, nodulo-ulcerative ocular surface squamous neoplasia is one such contribution. Her areas of research interest include retinoblastoma, ocular surface squamous neoplasia and sebaceous gland carcinoma and other ocular and periocular tumors. She is the section editor in ocular oncology for three international journals and a reviewer for over 20 prime journals.At the time of writing this description, Dr Swathi Kaliki has to her credit 212 publications in peer-reviewed journals and has delivered 256 conference lectures, including three keynote addresses. She has conducted 17 instruction courses and has been honored by 16 national and international awards.

BACK TO KALLAM ANJI REDDY CAMPUS, HYDERABAD